Regulatory, Pricing & Reimbursement

The PharmaBoardroom Regulatory, Pricing and Reimbursement collection covers the pricing frameworks, reimbursement pathways and health technology assessment processes that determine whether pharmaceutical products reach patients and generate commercial returns across major markets worldwide.

Pricing and reimbursement decisions are among the most commercially consequential in the pharmaceutical industry. Each market operates its own system, from AMNOG in Germany and NICE in the UK to the NRDL negotiation process in China and the SFDA framework in Saudi Arabia. Getting these submissions right requires detailed, country-specific knowledge.

Each guide is developed with a leading local law firm and kept up to date with the latest regulatory developments. Browse below to find the guide for your target market.